Journal Home
Search for

Volume 92, Issue 2, Pages 828.e3-828.e6 (August 2009)


View previous. 65 of 93 View next.

Crypt Y chromosome fragment resulting from an X;Y translocation in a patient with premature ovarian failure

De-Hua Cheng, M.Sc., Yue-Qiu Tan, Ph.D., Yu-Fen Di, M.Sc., Lu-Yun Li, M.D., Guang-Xiu Lu, M.D.Corresponding Author Informationemail address

Received 11 December 2007; received in revised form 17 May 2008; accepted 9 July 2008. published online 15 June 2009.

Objective

To identify a cryptic Y chromosome fragment that resulted from a X;Y translocation in a patient with premature ovarian failure (POF) and analyze the karyotype–phenotype correlation.

Design

Case report.

Setting

A university-based reproductive medicine center.

Patient(s)

A 33-year-old woman with POF.

Intervention(s)

Karyotyping analysis, comparative genomic hybridization, fluorescence in situ hybridization, and polymerase chain reaction (PCR) analysis for the patient.

Main Outcome Measure(s)

Karyotype determination of the patient.

Result(s)

The patient was suspected to carry an abnormal X chromosome by traditional cytogenetic analysis. A Y chromosome hybridization signal was found in the patient's genome by comparative genomic hybridization analysis. The fluorescence in situ hybridization result showed that the Y chromosome material resulted from a translocation between Xq and Yq. Using the specific sequence-tagged sites, the breakpoints on the X and Y chromosomes were located at Xq26.3 and Yq11.223, respectively. Combined with chromosome G banding and C banding, the karyotype of the patient was determined as 46,X,der(X)t(X;Y) (q26.3;q11.223).

Conclusion(s)

The advanced molecular cytogenetic techniques are helpful to detect cryptic chromosome aberrancies in patients with POF. This rare case supports that Xq26-q28 is the critical region of POF, and is helpful to analyze the risk of gonadoblastoma in patients with POF with Y chromosomal material.

Institute of Reproduction and Stem Cell Engineering, Reproductive and Genetic Hospital of Citic Xiangya, Central South University, Changsha, Peoples Republic of China

Corresponding Author InformationReprint requests: Guang-Xiu Lu, M.D., Institute of Reproduction and Stem Cell Engineering, Reproductive and Genetic Hospital of Citic Xiangya, Central South University, Changsha, 410078, P.R. China (FAX: 86-731-4497661).

 D.-H.C. has nothing to disclose. Y.-Q.T. has nothing to disclose. Y.-F.D. has nothing to disclose. L.-Y.L. has nothing to disclose. G.-X.L. has nothing to disclose.

 Supported by the Natural Science Foundation of Hunan Province of China (grant no. 2007FJ3068, Hunan Province) and the National Basic Research Program of China (grant no. 2007CB948103, Peking).

PII: S0015-0282(08)01465-9

doi:10.1016/j.fertnstert.2008.07.014


View previous. 65 of 93 View next.